Refine
Has Fulltext
- yes (5)
Is part of the Bibliography
- yes (5)
Document Type
- Journal article (4)
- Doctoral Thesis (1)
Keywords
- Alpha therapy (1)
- Autoimmune diseases (1)
- BCOR (1)
- BCORL1 (1)
- Bone marrow transplantantation (1)
- CMV (1)
- CMV-specific cellular immunity (1)
- Expression (1)
- Factor receptor (1)
- Graft-versus-leukemia (1)
Institute
- Medizinische Klinik und Poliklinik II (3)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (1)
- Institut für Virologie und Immunbiologie (1)
- Julius-von-Sachs-Institut für Biowissenschaften (1)
- Lehrstuhl für Orthopädie (1)
- Pathologisches Institut (1)
- Theodor-Boveri-Institut für Biowissenschaften (1)
Donor CD4\(^+\)Foxp3\(^+\) regulatory T cells (T reg cells) suppress graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation (HCT allo-HCT]). Current clinical study protocols rely on the ex vivo expansion of donor T reg cells and their infusion in high numbers. In this study, we present a novel strategy for inhibiting GvHD that is based on the in vivo expansion of recipient T reg cells before allo-HCT, exploiting the crucial role of tumor necrosis factor receptor 2 (TNFR2) in T reg cell biology. Expanding radiation-resistant host T reg cells in recipient mice using a mouse TNFR2-selective agonist before allo-HCT significantly prolonged survival and reduced GvHD severity in a TNFR2-and T reg cell-dependent manner. The beneficial effects of transplanted T cells against leukemia cells and infectious pathogens remained unaffected. A corresponding human TNFR2-specific agonist expanded human T reg cells in vitro. These observations indicate the potential of our strategy to protect allo-HCT patients from acute GvHD by expanding T reg cells via selective TNFR2 activation in vivo.
Die Patellaerstluxation ist eine besonders im jüngeren Lebensalter auftretende Verletzungsform. Bei persistierender Instabilität mit Rezidivereignissen ist die Rekonstruktion des medialen patellofemoralen Ligaments (MPFL) ein etabliertes Operationsverfahren.
In dieser Arbeit wurde bei 17 Patienten (Durchschnittsalter 22,65 Jahre) die posturale Stabilität sowie das Kraftverhalten der Oberschenkelmuskulatur im Mittel 400,65 Tage nach Durchführung einer MPFL-Plastik in Form einer klinischen Verlaufsstudie bestimmt.
Die Messung der posturalen Instabilität erfolgte im Einbeinstand auf einem Posturomed (Haider Bioswing). Dabei wurde aus der Ruheposition sowie nach Bewegungsimpuls in AP- und ML-Richtung die Wegstrecke der Standplattform aufgezeichnet. Bei allen Testmodi zeigten sich auf der operierten im Vergleich zur Gegenseite leichtgradig bessere Werte (nicht signifikant).
Die Kraftdiagnostik erfolgte durch isokinetische Testung der Kniegelenksextensoren bzw. -flexoren im Seitenvergleich mittels Biodex System 3 (Medical Systems) zunächst unter konzentrischen Kontraktionsbedingungen bei 60°/s und 240°/s sowie im Anschluss bei exzentrischer Flexion bei 60°/s Winkelgeschwindigkeit. Im ersten Abschnitt zeigten sich auf der betroffenen Seite in die Knieextension niedrigere Werte als auf der Gegenseite (teilweise signifikant) bei keiner wesentlichen Differenz in die Flexion. Im zweiten Teil erzielten die Probanden im Mittel mit ihrem operierten Bein geringere Werte als mit dem nicht operierten Bein (teilweise signifikant).
Zusammenfassend zeigt sich ca. ein Jahr postoperativ kein posturales Defizit jedoch ein Kraftdefizit des Streckapparates der operierten Seite. In der Literatur ist eine postoperative Quadrizepsdsyfunktion nach MPFL-Plastik vielfach beschrieben. Ein möglicher Pathomechanismus ist die arthrogene Muskelinhibition. Die Integration disinhibierender Maßnahmen in herkömmliche Rehabilitationsprogramme stellt einen denkbaren Therapieansatz dar.
Acute myeloid leukemia (AML) is characterized by recurrent genetic events. The BCL6 corepressor (BCOR) and its homolog, the BCL6 corepressor-like 1 (BCORL1), have been reported to be rare but recurrent mutations in AML. Previously, smaller studies have reported conflicting results regarding impacts on outcomes. Here, we retrospectively analyzed a large cohort of 1529 patients with newly diagnosed and intensively treated AML. BCOR and BCORL1 mutations were found in 71 (4.6%) and 53 patients (3.5%), respectively. Frequently co-mutated genes were DNTM3A, TET2 and RUNX1. Mutated BCORL1 and loss-of-function mutations of BCOR were significantly more common in the ELN2017 intermediate-risk group. Patients harboring loss-of-function mutations of BCOR had a significantly reduced median event-free survival (HR = 1.464 (95%-Confidence Interval (CI): 1.005–2.134), p = 0.047), relapse-free survival (HR = 1.904 (95%-CI: 1.163–3.117), p = 0.01), and trend for reduced overall survival (HR = 1.495 (95%-CI: 0.990–2.258), p = 0.056) in multivariable analysis. Our study establishes a novel role for loss-of-function mutations of BCOR regarding risk stratification in AML, which may influence treatment allocation.
Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality following hematopoietic stem cell transplantation (HSCT). Measuring CMV-specific cellular immunity may improve the risk stratification and management of patients. IFN-γ ELISpot assays, based on the stimulation of peripheral blood mononuclear cells with CMV pp65 and IE-1 proteins or peptides, have been validated in clinical settings. However, it remains unclear to which extend the T-cell response to synthetic peptides reflect that mediated by full-length proteins processed by antigen-presenting cells. We compared the stimulating ability of pp65 and IE-1 proteins and corresponding overlapping peptides in 16 HSCT recipients using a standardized IFN-γ ELISpot assay. Paired qualitative test results showed an overall 74.4% concordance. Discordant results were mainly due to low-response tests, with one exception. One patient with early CMV reactivation and graft-versus-host disease, sustained CMV DNAemia and high CD8\(^+\) counts showed successive negative protein-based ELISpot results but a high and sustained response to IE-1 peptides. Our results suggest that the response to exogenous proteins, which involves their uptake and processing by antigen-presenting cells, more closely reflects the physiological response to CMV infection, while the response to exogenous peptides may lead to artificial in vitro T-cell responses, especially in strongly immunosuppressed patients.
Land-use intensification is a major driver of biodiversity loss. However, understanding how different components of land use drive biodiversity loss requires the investigation of multiple trophic levels across spatial scales. Using data from 150 agricultural grasslands in central Europe, we assess the influence of multiple components of local- and landscape-level land use on more than 4,000 above- and belowground taxa, spanning 20 trophic groups. Plot-level land-use intensity is strongly and negatively associated with aboveground trophic groups, but positively or not associated with belowground trophic groups. Meanwhile, both above- and belowground trophic groups respond to landscape-level land use, but to different drivers: aboveground diversity of grasslands is promoted by diverse surrounding land-cover, while belowground diversity is positively related to a high permanent forest cover in the surrounding landscape. These results highlight a role of landscape-level land use in shaping belowground communities, and suggest that revised agroecosystem management strategies are needed to conserve whole-ecosystem biodiversity.